Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Humulus japonicus is an annual herbaceous vine of the Cannabaceae family, commonly known as Japanese hops or wild hops, native to East Asia and used in traditional medicine for conditions such as hypertension, diarrhea, pulmonary disease, skin disease, and leprosy. Unlike common hop (Humulus lupulus), it is not used in brewing, but rather as an herbal remedy. Its extracts and active constituents exhibit anti-inflammatory, anti-oxidative, anti-microbial, anti-tumor, neuroprotective, anti-atherosclerotic, and anti-obesity effects. Studies indicate mechanisms including antioxidant activity, suppression of inflammatory mediators (e.g., inhibition of COX-2, iNOS, TNF-α, IL-1β, IL-6), modulation of apoptosis pathways, and regulation of lipogenesis/lipolysis in metabolic disease models. The key compound luteolin 7-O-β-d-glucoside is implicated in the metabolic actions. Humulus japonicus is regarded as a promising candidate for the prevention or treatment of diseases such as Parkinson’s disease, rheumatoid arthritis, nonalcoholic fatty liver disease, hypertension, metabolic syndrome, and obesity[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on humulus japonicus.